Prostate Artery Embolization (PAE) offers a minimally invasive treatment for Benign Prostatic Hyperplasia (BPH). Suitable for ...

Malaysia’s Sunway Medical Centre has announced a partnership with United Imaging Healthcare to advance prostate cancer diagnosis and treatment monitoring.

OncoAssure Ltd, an Irish medical diagnostic company, today announced the publication of new data, in the British Journal of Urology International Compass (BJUI Compass), which demonstrates the ...

For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk ...

In 2023 alone, 288,300 new cases of prostate cancer will be diagnosed in the United States, according to the American Cancer ...

A new test for prostate cancer developed by Irish and Swedish researchers better predicts the risks of the aggressive disease ...

High intensity focused ultrasound (HIFU) is a novel prostate cancer treatment that minimizes side effect while destroying ...

OncoAssure Ltd, an Irish medical diagnostic company, announced the publication of new data in the journal BJUI Compass that ...

One year after surgery, 97% of patients in the ≥ 85 group and 100% of patients in the control group could void spontaneously.

A Bermudian genome researching organisation helped to unveil a project designed to pinpoint the genetic factors that make ...

Learn how an enlarged prostate and Parkinsonism can overlap, impact daily life, and be managed effectively for better health.